IMatinib Para-diaMinoMethylbenzene manufacturers
|
| IMatinib Para-diaMinoMethylbenzene Basic information |
Product Name: | IMatinib Para-diaMinoMethylbenzene | Synonyms: | IMatinib Para-diaMinoMethylbenzene;Imatinib Impurity H;4-[(4-Methyl-1-piperazinyl)methyl]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide;Imatinib impuritiesD;IMatinib Para-diaMinoMethylbenzene USP/EP/BP;Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;Imatinib Para PPA Imp;Imatinib para-PPA Impurity | CAS: | 1026753-54-7 | MF: | C29H31N7O | MW: | 493.6 | EINECS: | | Product Categories: | | Mol File: | 1026753-54-7.mol | ![IMatinib Para-diaMinoMethylbenzene Structure](CAS/20180808/GIF/1026753-54-7.gif) |
| IMatinib Para-diaMinoMethylbenzene Chemical Properties |
Melting point | >115°C (dec.) | density | 1?+-.0.06 g/cm3(Predicted) | storage temp. | Refrigerator | solubility | Chloroform (Slightly), DMSO (Sparingly), Methanol (Slightly) | form | Solid | pka | 13.17±0.70(Predicted) | color | Off-White to Yellow |
| IMatinib Para-diaMinoMethylbenzene Usage And Synthesis |
Uses | Imatinib para-Diaminomethylbenzene is an impurity of Imatinib, a tyrosine kinase inhibitor. It is a COVID19-related research product. |
| IMatinib Para-diaMinoMethylbenzene Preparation Products And Raw materials |
|